Industry stewardship
Cencora is advocating for public policies to address drug shortages and partnering with experts across the supply chain to build a more resilient supply chain.
Cencora supports public policies to:
Cencora supports public policies to:
- Foster and create public-private relationships to use the pharmaceutical distribution industry and vendor managed inventory to hold buffer inventory of essential generic medications that are often in shortage and critical in need (short-term solution)
- Establish manufacturing incentives to support U.S. manufacturing of API pharmaceuticals, while also continuing to promote supplier diversity
- Adequate and fair reimbursement for pharmacies and physicians for medications administered and reimbursed through Medicare
- Disclose operational and inventory data to manufacturers via a robust supply chain and data analytics platform, enabling proactive management of shipments to distribution centers based on their urgent requirements
Whitepaper
Addressing generic drug shortages: Contributing factors and public policy recommendations
To address the underlying drivers of generic drug shortages, policymakers must take a comprehensive, multi-pronged approach on three goals: enabling sustainable and reliable generic drug manufacturing, increasing stability of supply, and improving the resilience of the domestic supply chain.
Download the whitepaper for a complete outline of our recommendations to combat generic drug shortages or view the executive summary by clicking here.
We are united in our responsibility to create healthier futures
Through our businesses, we are well-positioned to understand the complexity of the pharmaceutical supply chain, the drivers and impacts of disruptions to the supply chain, and the solutions — including policy – needed to prevent shortages.